Jasmine Perfume USA – Trademark Portfolio

Entity Type: 16

Jasmine Perfume USA holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include JASMINE BEAUTY & CARE. The owner is based in Houston, TX.

6345 Skyline Drive

Houston, TX 77057

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Jasmine Perfume USA's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Jasmine Perfume USA have?

Jasmine Perfume USA has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Jasmine Perfume USA file in?

Jasmine Perfume USA files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Jasmine Perfume USA's most well-known trademarks?

Jasmine Perfume USA's registered trademark portfolio includes well-known marks such as JASMINE BEAUTY & CARE. These are among 1 currently registered trademark in the portfolio.

What is Jasmine Perfume USA's trademark registration success rate?

Jasmine Perfume USA has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.